167 related articles for article (PubMed ID: 24345448)
1. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
[TBL] [Abstract][Full Text] [Related]
2. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
3. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).
Gorsuch S; Bavetsias V; Rowlands MG; Aherne GW; Workman P; Jarman M; McDonald E
Bioorg Med Chem; 2009 Jan; 17(2):467-74. PubMed ID: 19101154
[TBL] [Abstract][Full Text] [Related]
5. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
6. New potent bisubstrate inhibitors of histone acetyltransferase p300: design, synthesis and biological evaluation.
Kwie FH; Briet M; Soupaya D; Hoffmann P; Maturano M; Rodriguez F; Blonski C; Lherbet C; Baudoin-Dehoux C
Chem Biol Drug Des; 2011 Jan; 77(1):86-92. PubMed ID: 21118378
[TBL] [Abstract][Full Text] [Related]
7. Probing the reaction coordinate of the p300/CBP histone acetyltransferase with bisubstrate analogs.
Karukurichi KR; Cole PA
Bioorg Chem; 2011 Feb; 39(1):42-7. PubMed ID: 21111442
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
[TBL] [Abstract][Full Text] [Related]
9. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.
Mai A; Rotili D; Tarantino D; Nebbioso A; Castellano S; Sbardella G; Tini M; Altucci L
Bioorg Med Chem Lett; 2009 Feb; 19(4):1132-5. PubMed ID: 19144517
[TBL] [Abstract][Full Text] [Related]
10. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
Bowers EM; Yan G; Mukherjee C; Orry A; Wang L; Holbert MA; Crump NT; Hazzalin CA; Liszczak G; Yuan H; Larocca C; Saldanha SA; Abagyan R; Sun Y; Meyers DJ; Marmorstein R; Mahadevan LC; Alani RM; Cole PA
Chem Biol; 2010 May; 17(5):471-82. PubMed ID: 20534345
[TBL] [Abstract][Full Text] [Related]
11. Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases.
Sbardella G; Castellano S; Vicidomini C; Rotili D; Nebbioso A; Miceli M; Altucci L; Mai A
Bioorg Med Chem Lett; 2008 May; 18(9):2788-92. PubMed ID: 18434144
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.
Furdas SD; Shekfeh S; Bissinger EM; Wagner JM; Schlimme S; Valkov V; Hendzel M; Jung M; Sippl W
Bioorg Med Chem; 2011 Jun; 19(12):3678-89. PubMed ID: 21353783
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities.
Souto JA; Conte M; Alvarez R; Nebbioso A; Carafa V; Altucci L; de Lera AR
ChemMedChem; 2008 Sep; 3(9):1435-42. PubMed ID: 18537201
[TBL] [Abstract][Full Text] [Related]
14. 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.
Ghizzoni M; Wu J; Gao T; Haisma HJ; Dekker FJ; George Zheng Y
Eur J Med Chem; 2012 Jan; 47(1):337-44. PubMed ID: 22100137
[TBL] [Abstract][Full Text] [Related]
15. Protein modification by strain-promoted alkyne-azide cycloaddition.
van Hest JC; van Delft FL
Chembiochem; 2011 Jun; 12(9):1309-12. PubMed ID: 21557431
[No Abstract] [Full Text] [Related]
16. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator.
Liu X; Wang L; Zhao K; Thompson PR; Hwang Y; Marmorstein R; Cole PA
Nature; 2008 Feb; 451(7180):846-50. PubMed ID: 18273021
[TBL] [Abstract][Full Text] [Related]
17. Isothiazolones; thiol-reactive inhibitors of cysteine protease cathepsin B and histone acetyltransferase PCAF.
Wisastra R; Ghizzoni M; Maarsingh H; Minnaard AJ; Haisma HJ; Dekker FJ
Org Biomol Chem; 2011 Mar; 9(6):1817-22. PubMed ID: 21267493
[TBL] [Abstract][Full Text] [Related]
18. Characterization of novel inhibitors of histone acetyltransferases.
Eliseeva ED; Valkov V; Jung M; Jung MO
Mol Cancer Ther; 2007 Sep; 6(9):2391-8. PubMed ID: 17876038
[TBL] [Abstract][Full Text] [Related]
19. Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase.
Ghizzoni M; Haisma HJ; Dekker FJ
Eur J Med Chem; 2009 Dec; 44(12):4855-61. PubMed ID: 19683843
[TBL] [Abstract][Full Text] [Related]
20. Current development of CBP/p300 inhibitors in the last decade.
He ZX; Wei BF; Zhang X; Gong YP; Ma LY; Zhao W
Eur J Med Chem; 2021 Jan; 209():112861. PubMed ID: 33045661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
